secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001372514-24-000057
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora Pharmaceuticals announces 1-for-9 reverse stock split effective June 11, 2024 to meet Nasdaq bid price requirement
--------------------------------------------------------------------------------

- 1-for-9 reverse stock split filed June 6, 2024; effective at open of market on June 11, 2024.
- Outstanding shares will reduce from ~26.7M to ~2.97M; fully diluted from ~100.1M to ~11.1M.
- Class D warrants for 3.43M shares expired on June 6, 2024; other warrants adjust proportionally.
- No change to authorized shares, par value ($0.01), or ticker (KPRX); fractional shares paid in cash.
- Reverse split is intended to maintain compliance with Nasdaq minimum bid price requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251424000057/0001372514-24-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251424000057/kprx-20240606.htm
  HTML page:      https://secwatch.observer/filing/0001372514-24-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer